1988
DOI: 10.1227/00006123-198812000-00001
|View full text |Cite
|
Sign up to set email alerts
|

Use of Implantable Pumps for Central Nervous System Drug Infusions to Treat Neurological Disease

Abstract: Increasing knowledge of the neurochemical aspects of central nervous system function raises the possibility of treating neurological disease by the appropriate manipulation of neurotransmitters, neuromodulators, and neurohormones. Clinical application of this knowledge has been inhibited, however, by long-standing problems with drug delivery to the central nervous system (CNS). The availability of implantable drug infusion pumps and stereotactic catheter placement techniques may overcome many of these problems… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
1
1

Year Published

1990
1990
2013
2013

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 61 publications
(13 citation statements)
references
References 0 publications
0
11
1
1
Order By: Relevance
“…Osmotic minipumps are commonly used for delivering substances over a long period of time (Harbaugh et al, 1988). In our studies, plasma cocaine concentrations were measured to determine whether there was any variability due to partial occlusion of the pumps, which can occur over a period of time (Jones et al, 2001).…”
Section: Discussionmentioning
confidence: 99%
“…Osmotic minipumps are commonly used for delivering substances over a long period of time (Harbaugh et al, 1988). In our studies, plasma cocaine concentrations were measured to determine whether there was any variability due to partial occlusion of the pumps, which can occur over a period of time (Jones et al, 2001).…”
Section: Discussionmentioning
confidence: 99%
“…This is invasive and expensive to perform and may only be useful for acute administration of drugs. Nevertheless, direct injections into the CNS could be a useful way of introducing longer‐acting slow‐release preparations, implanted devices 51 or genetically modified cells that are able to produce drugs in situ , secreting them directly into the CNS 52 …”
Section: Strategies That Do Not Involve Modifications In the Moleculamentioning
confidence: 99%
“…However, both techniques used in this study have advantages and disadvantages. Some aspects of this issue have been discussed previously (Harbaugh et al, 1988;Williams et al, 1987).…”
mentioning
confidence: 99%